Abstract
People infected with human immunodeficiency virus (HIV) are living longer thanks to effective antiretroviral therapy. As this population ages, cardiovascular disease is becoming an important cause of morbidity and death. The authors of this review discuss the magnitude and likely mechanisms of the risk and strategies for managing it.
MeSH terms
-
Anti-Retroviral Agents / adverse effects
-
Anticholesteremic Agents / adverse effects
-
Coronary Disease / etiology*
-
Coronary Disease / prevention & control
-
Diabetes Mellitus / physiopathology
-
Dyslipidemias / drug therapy
-
Dyslipidemias / etiology
-
HIV Infections / complications*
-
HIV Infections / drug therapy
-
HIV Infections / physiopathology
-
Health Behavior
-
Humans
-
Insulin Resistance
-
Lipoproteins / drug effects
-
Lipoproteins / metabolism
-
Risk Factors
Substances
-
Anti-Retroviral Agents
-
Anticholesteremic Agents
-
Lipoproteins